Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

CATX holding history

Perspective Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CATX overviewAll 13F holders of CATXFull Q2 2026 holdings

Shares (Q2 2026)
1,912,550
Value
$6.52M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CATX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,912,550$6.52M<0.1%−1,070,792−35.9%ReducedHolders
Q1 20262,983,342$12.4M<0.1%−1,491,180−33.3%ReducedHolders
Q4 20254,474,522$12.3M<0.1%+1,713,661+62.1%AddedHolders
Q3 20252,760,861$9.47M<0.1%+1,137,473+70.1%AddedHolders
Q2 20251,623,388$5.58M<0.1%+64,937+4.2%AddedHolders
Q1 20251,558,451$3.32M<0.1%+414,989+36.3%AddedHolders
Q4 20241,143,462$3.65M<0.1%+858,061+300.7%AddedHolders
Q3 2024285,401$3.81M<0.1%+133,505+87.9%AddedHolders
Q2 2024151,896$1.51M<0.1%−622,459−80.4%ReducedHolders
Q1 2024774,355$921.5K<0.1%+717,388+1,259.3%AddedHolders
Q4 202356,967$22.9K<0.1%00.0%UnchangedHolders
Q3 202356,967$15.6K<0.1%−5,184−8.3%ReducedHolders
Q2 202362,151$41.5K<0.1%−9,089−12.8%ReducedHolders
Q1 202371,240$45.5K<0.1%−12,786−15.2%ReducedHolders
Q4 202284,026$20.8K<0.1%−10.0%ReducedHolders
Q3 202284,027$19.0K<0.1%−320.0%ReducedHolders
Q2 202284,059$26.0K<0.1%−6,571−7.3%ReducedHolders
Q1 202290,630$33.0K<0.1%+14,397+18.9%AddedHolders
Q4 202176,233$30.0K<0.1%+90.0%AddedHolders
Q3 202176,224$48.0K<0.1%00.0%UnchangedHolders
Q2 202176,224$61.0K<0.1%+74,024+3,364.7%AddedHolders
Q1 20212,200$2.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.